time, preferably those with complementary mechanisms ofaction. 3,4Recent guidelines recommend early use of basal insulin as an option for patients with poor glycaemic control with oraltherapies. 3–5Received: 8 December 2017 Revised: 12 February 2018 Accepted: 19 February 2018 DOI: 10.1111/dom.13266 This is an open access article under the terms of the Creative Commons Attribution ‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. © 2018 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd. 1602 wileyonlinelibrary.com/journal/dom Diabetes Obes Metab. 2018; 20:1602 –1614.